Neurochemical Research

, Volume 19, Issue 8, pp 1073–1082 | Cite as

Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil)

  • Magnhild Rasmussen
  • Ann B. Moser
  • Janet Borel
  • Surinder Khangoora
  • Hugo W. Moser
Original Articles


Brain, liver, and adipose lipids were studied in the postmortem tissues of four adrenoleukodystrophy patients who had been treated with a mixture of glyceryl trioleate and trierucate olis (“Lorenzo's Oil”) and compared to 7 untreated ALD patients and 3 controls. The dietary therapy appeared to reduce the levels of saturated very long chain fatty acids in the plasma, adipose tissue and liver; in the brain they were reduced in only one of the four patients. While substantial amounts of erucic acid were present in some of the tissues even 12 months after therapy had been discontinued, the levels in brain did not exceed those in controls at any time. The failure of erucic acid to enter the brain in significant quantity may be a factor in the disappointing results of dietary therapy for adrenoleukodystrophy.

Key Words

Adrenoleukodystrphy erucic acid very long chain fatty acids dietary therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moser, H. W., and Moser, A. B. 1989. X-Linked adrenoleukodystrophy. Pages 1511–1532,in Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D. (eds.) The Metabolic Basis of Inherited Disease. Sixth Edition ed. New York: McGraw Hill.Google Scholar
  2. 2.
    Lazo, O., Contreras, M., Hashmi, M., Stanley, W., Irazu, C., and Singh, I. 1988. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA. 85:7647–7651.Google Scholar
  3. 3.
    Mosser, J., Douar, A. M., Sarde, C. O., Kioschis, P., Feil, R., Moser, H., Poustka, A. M., Mandel, J. M., and Aubourg, P. 1993. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:726–730.Google Scholar
  4. 4.
    Moser, H. W., Moser, A. B., Smith, K. D., Bergin, A., Borel, J., Shankroff, J., Stine, O. C., Merette, C., Ott, J., Krivit, W., and Shapiro, E. 1992. E. Adrenoleukodystrophy: Phenotypic variability: Implications for therapy. J Inher Metab Dis. 15:645–664.Google Scholar
  5. 5.
    Igarashi, M., Schaumburg, H. H., Powers, J., Kishimoto, Y., Kolodny, E., and Suzuki, K. 1976. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 26:851–860.Google Scholar
  6. 6.
    Theda, C., Moser, A. B., Powers, J. M., and Moser, H. W. 1992. Phospholipids in X-linked adrenoleukodystrophy white matter. Fatty acid abnormalities before the onset of demyelination. J Neurol Sci. 110:195–204.Google Scholar
  7. 7.
    Kishimoto, Y., Moser, H. W., Kawamura, N., Platt, M., Pallante, B., and Fenselau, C. 1980. Evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. Biochem Biophys Res Commun. 96:69–76.Google Scholar
  8. 8.
    Van Duyn, M. A., Moser, A. B., Brown III, F. R., Sacktor, N., Liu, A., and Moser, H. W. 1984. The design of a diet restricted in saturated very long chain fatty acids: Therapeutic application in adrenoleukodystrophy. Am J Clin Nutr. 40:277–284.Google Scholar
  9. 9.
    Brown III, F. R., Van Duyn, M. A., Moser, A. B., Schulman, J. D., Rizzo, W. B., Snyder, R. D., Murphy, J. V., Kamoshita, S., Migeon, C. J., and Moser, H. W. 1982. Adrenoleukodystrophy: Effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. Johns Hopkins Med J. 151:164–172.Google Scholar
  10. 10.
    Bourre, J. M., Daudu, O., and Baumann, N. 1976. Nervonic acid biosynthesis by erucyl-CoA elongation in normal and quaking mouse brain microsomes. Elongation of other unsaturated fatty acyl-CoAs (mono and polyunsaturated). Biochim Biophys Acta. 424:1–7.Google Scholar
  11. 11.
    Tsuji, S., Sano-Kawamura, T., Ariga, T., and Miyatake, T. 1985. Metabolism of (17,18-3H2) hexacosanoic acid and (15,16–3h2) lignoceric acid in cultured skin fibroblasts from patients with adrenolcukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Neurol Sci. 71:359–367.Google Scholar
  12. 12.
    Rizzo, W. B., Watkins, P. A., Phillips, M. W., Cranin, D., Campbell, B., and Avigan, J. 1986. Adrenoleukodystrophy: Oleic acid lowers fibroblast saturated C22–C26 fatty acids. Neurology. 36:357–361.Google Scholar
  13. 13.
    Rizzo, W. B., Phillips, M. W., Dammann, A. L., Leshner, R. Y., and Jennings, S. V. K. 1987. Adrenoleukodystrophy: Dietary oleic acid lowers hexacosanoate levels. Ann Neurol. 21:232–239.Google Scholar
  14. 14.
    Moser, A. B., Borel, J., Odone, A., Naidu, S., Cornblath, D., Sanders, D. B., and Moser, H. W. 1987. A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patients. Ann Neurol. 21:240–249.Google Scholar
  15. 15.
    Moser, H. W., Aubourg, P., Cornblath, D., Borel, J., Wu, Y. W., Bergin, A., Naidu, S., and Moser, A. B. The Therapy for X-Linked Adrenoleukodystrophy. Desnick, R. J. Treatment of Genetic Diseases. New York: Churchill Livingstone; 1991(Chapter 7):111–129.Google Scholar
  16. 16.
    Rizzo, W. B., Leshner, R. T., Odone, A., Dammann, A. L., Craft, D. A., Jensone, M. E., Jennings, S. S., Davis, S., Jaitly, R., and Sgro, J. A. 1989. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology. 39(11):1415–1422.Google Scholar
  17. 17.
    Odone, A., and Odone, M. 1989. Lorenzo's oil. A new treatment for adrenoleukodystrophy. J. Pediatr Neurosci. 5:55–61.Google Scholar
  18. 18.
    Rizzo, W. B., Leshner, R. T., Odone, A., Craft, D. A., Jennings, S. S., Jaitly, R., and Segro, J. A. 1990. X-linked adrenoleukodystrophy: Biochemical and clinical efficacy of dietary erucic acid therapy. Pages 149– Uziel, G., Wanders, R. J. A., Cappa, M. Adrenoleukodystrophy and other peroxisomal disorders. Amsterdam: Excerpta Medica; (International Congress Series 898).Google Scholar
  19. 19.
    Uziel, G., Bertini, E., Rimoldi, M., and Gambetti, M. 1990. Italian multicentric dietary therapeutical trial in adrenoleukodystrophy. Pages 163– Uziel, G., Wanders, R. J. A., and Cappa, M. (eds.), Adrenoleukodystrophy and Other Peroxisomal Disorders: Clinical, Biochemical, Genetic and Therapeutic Aspects. International Congress Series 898 ed. Amsterdam: Elsevier Science Publishers.Google Scholar
  20. 20.
    Kaplan, P. W., Tusa, R. J., Shankroff, J., Heller, J. E., and Moser, H. W. 1993. Visual evoked potentials in adrenoleukodystrophy: A trial with Lorenzo oil. Ann Neurol. 34(2):169–174.Google Scholar
  21. 21.
    Aubourg, P., Adamsbaum, C., Lavallard-Rousseau, M. C., Rocchiccioli, F., Cartier, N., Jambaque, I., Jakobezak, C., Lemaitre, A., Boureau, F., Wolf, C., and Bougneres, P. F. 1993. A twoyear trial of oleic and erucic acids (“Lorenzo's oil”) as treatment for adrenoleukodystrophy. N Engl J Med. 329:745–752.Google Scholar
  22. 22.
    Moser, H. W. 1993. Lorenzo oil therapy for adrenoleukodystrophy: A prematurely amplified hope. Ann Neurol. 34(2):121–122.Google Scholar
  23. 23.
    Rizzo, W. B. 1993. Lorenzo's oil–Hope and disappointment. N Engl J Med. 329(11):801–802.Google Scholar
  24. 24.
    Moser, H. W. 1993. Lorenzo's oil. Film Review. Lancet. 341:544.Google Scholar
  25. 25.
    Stephen, A. M., and Wald, N. J. 1990. Trends in individual consumption of dietary fat in the United States. Am J Clin Nutr. 52:457–469.Google Scholar
  26. 26.
    Simopoulos, A. P. 1989. Executive summary, in Dietary Omega-3 and Omega-6 Fatty Acids-Biological Effects and Nutritional Essentiality. Galli, C., and Simopoulos, A. P. (Eds). New York: Plenum; 391–404.Google Scholar
  27. 27.
    Borel, J. S. 1992. Adrenoleukodystrophy and Related Peroxisomal Disorders. In: Ekvall, S. (Ed.). Pediatric Nutrition in Developmental Disorders and Chronic Diseases. : Oxford University; 1992(in press).Google Scholar
  28. 28.
    Borel, J., and Cohen, J. 1990. Editors. ALD/AMN Diet Cookbook. Second Edition ed. DeKalb; Baltimore: United Leukodystrophy Foundation and The Kennedy Institute; 1–274.Google Scholar
  29. 29.
    Folch, J., Lees, M., and Stanley, S. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:497–509.Google Scholar
  30. 30.
    Vance, D. E., and Sweely, C. C. 1967. J Lipid Res. 8:621–630.Google Scholar
  31. 31.
    Moser, H. W., and Moser, A. B. 1991. Measurements of Saturated Very Long Chain Fatty Acids in Plasma. Pages 177– Hommes, F. (ed). Techniques in Diagnostic Human Biochemical Genetics. Chapter 12: New York: Wiley-Liss, Inc.Google Scholar
  32. 32.
    Taketomi, T., Hara, A., Kitazawa, N., Takada, K., and Nakamura, H. 1987. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy: 2. lipid abnormalities. Jpn J Exp Med. 57:59–70.Google Scholar
  33. 33.
    Reinecke, C. J., Knoll, D. P., Pretorius, P. J., Steyn, H. S., and Simpson, R. H. W. 1985. The correlation between biochemical and histopathological findings in adrenoleukodystrophy. J Neurol Sci. 70:21–38.Google Scholar
  34. 34.
    Foote, S., Vollrath, D., Hilton, A., and Page, D. C. 1992. The human Y chromosome: Overlapping DNA clones spanning the euchromatic region. Science. 258:60–66.Google Scholar
  35. 35.
    Bourre, J. M., Dumont, O., Pascal, G., and Durand, G. 1993. Dietary alpha-linolenic acid at 1.3 g/kg maintains maximal docosahexaenoic acid concentration in brain, heart and liver of adult rats. J Nutr. 123:1313–1319.Google Scholar
  36. 36.
    Li, J., Wetzel, M. G., and O'Brien, P. J. 1992. Transport of n-3 fatty acids from the intestine to the retina in rats. J Lipid Res. 33:539–548.Google Scholar
  37. 37.
    Nilsson, A., Hjelte, L., and Strandvik, B. 1992. Incorporation of dietary [14C]arachidonic acid and [3H]eicosapentaenoic acid into tissue lipids during absorption of a fish oil emulsion. J Lipid Res. 33:1295–1305.Google Scholar
  38. 38.
    Scott, B. L., and Bazan, N. G. 1989. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci. 86:2093–2097.Google Scholar
  39. 39.
    Zinkham, W. H., Kickler, T., Borel, J., and Moser, H. W. 1993. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. N Engl J Med. 328(15):1126–1127.Google Scholar
  40. 40.
    Moser, H. W., Kok, F., Neumann, S., Borel, J., Bergin, A., Darwish, Mostava S., Panoscha, R., Davoli, C. T., Shankroff, J., and Smith, K. D. Adrenoleukodystrophy update: Genetics and effect of Lorenzo's oil therapy in asymptomatic patients. Int Pediatr, in press.Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Magnhild Rasmussen
    • 1
  • Ann B. Moser
    • 1
  • Janet Borel
    • 1
  • Surinder Khangoora
    • 1
  • Hugo W. Moser
    • 1
  1. 1.Department of NeurogeneticsThe Kennedy Krieger InstituteBaltimore

Personalised recommendations